<DOC>
	<DOCNO>NCT00279929</DOCNO>
	<brief_summary>The role dehydroepiandosterone ( DHEA ) sulphated ester ( DHEAS ) [ together know DHEA ( S ) ] human remain fully elucidate . They abundant circulate steroid hormone human principle source production adrenal gland . In adrenalectomised hypoadrenal subject standard clinical practice replace hormone . Whilst lack DHEA ( S ) clearly life threatening , publish literature psychological effect replacement population show benefit quality life data concern metabolic effect conflict incomplete . We wish carry study measure effect DHEA ( S ) replacement group adrenalectomised / hypoadrenal subject measure outcome number psychological metabolic parameter prior twelve week 50 mg/day DHEA ( S ) double blind randomise cross design . Mood , quality life sexual well assess use validated questionnaire . In addition , utilise GCRC facility measure body composition use total body water DEXA . We measure insulin sensitivity , exercise performance , muscle fatigability VO2 max . Pre- post- intervention muscle biopsy assess DHEA ( S ) effect myosin heavy chain isoform expression ; skeletal muscle mitochondrial ATP production use assess muscle enzyme level .</brief_summary>
	<brief_title>DHEA Replacement Adrenalectomized/Hypoadrenal Patients</brief_title>
	<detailed_description />
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Inclusion criterion : Subjects adrenalectomised hypoadrenal ( whatever cause ) &gt; 24 month ; Subjects steady glucocorticoid replacement regime &gt; 12 month ; Women child bear age oestrogen status steady &gt; 6 month i.e . either oral contraceptive pill time ; Subjects form hormone replacement therapy ( e.g . thyroxin ) dose remain &gt; 6 month . Exclusion criterion : BMI &gt; 35 Kg/m2 ; Individuals fast blood glucose 120mg/dl ; A history sex hormone dependant malignancy ; A history liver disease ; Renal failure ; Cardiovascular disease ( hypertension ) ; Polycythaemia ; Pregnancy breastfeeding ; Cerebrovascular disorder ; Neurological disorder ; PSA level age relate reference range ; Use drug know alter mood within 6 month prior enrolment ; Any drug know affect hepatic biotransformation ; Evidence psychiatric disease dementia ; Postmenopausal woman hormone replacement therapy less six month .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>